YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M 0 27.08.2024 16:56 Fiercebiotech.com YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M jwaldron Tue, 08/27/2024 - 09:56
